The Promise of Tumor Mutational Burden for Cancer Immunotherapy
Quantitative Biomarkers Could Be the Next Step for Precision Oncology
Just Enough Downstream Innovation
Downstream Operations Can Relieve the Pressure of Higher Titers and Cell Densities without Undue Disruption
Snag-Free Combing of the Proteome
With the Right Conditioning Raw Samples May Become More Manageable
Love, Science, and Autoimmune Therapy
NYU Professor Advances Autoimmune Disease Therapeutics
For full access to this article login to GEN Select now.
Cancer Genome Researchers Band Together
Joint Effort Seeks to Describe Changes in 50 Tumor Types
- Cancer is a leading and growing cause of death worldwide, accounting for more than 7 million deaths in 2004, representing 13% of all cases of mortality. The World Health Organization estimates the number of annual cancer deaths will rise to 12 million in 2030. Cancer is not just a ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.